These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5157412)

  • 21. Effect of aminogluthethymide on urinary excretion of corticotropin and adrenal hormones.
    Hartwig W; Migdalska B; Kasperlik-Zasluska A
    Pol Med J; 1969; 8(3):529-39. PubMed ID: 4309004
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reduced excretion of total gonadotropins during use of Elipten in breast neoplasms].
    Eliubaeva GO; Sanchakova AV; Vishnevskiĭ AS; Dil'man VM
    Vopr Onkol; 1972; 18(3):92-3. PubMed ID: 5017847
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of aminoglutethimide in the treatment of adrenal gland hyperfunction].
    Neumann P; Knappe G; Stahl F; Kublun G; Bruns W; Wulfert P
    Z Gesamte Inn Med; 1979 May; 34(9):247-53. PubMed ID: 225896
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of eliptene aminoglutethimide on the excretion of gonadotropins and phenol steroids (preliminary study)].
    Dil'man VM; Krylova NV; Tsyrlina EV; Vishnevskiĭ AS
    Vopr Onkol; 1969; 15(3):94-5. PubMed ID: 5406696
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of aminoglutethimide on excretion of ACTH and adrenal hormones].
    Hartwig W; Migdalska B; Kasperlik-Zaluska A
    Pol Arch Med Wewn; 1968; 41(2):167-77. PubMed ID: 4302699
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of secondary hyperaldosteronism].
    Werning C; Siegenthaler W
    Dtsch Med Wochenschr; 1969 Oct; 94(40):2051-3. PubMed ID: 5356332
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibitions of steroid biosynthesis in the adrenal gland by aminogluthetimide (Elipten CIBA) and its practical significance].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Vnitr Lek; 1969 May; 15(5):417-25. PubMed ID: 5792533
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medical therapy of hyperadrenalism].
    Raith L
    Minerva Med; 1973 Mar; 64(14):682-4. PubMed ID: 4350585
    [No Abstract]   [Full Text] [Related]  

  • 29. [Further experience with the long-term treatment with aminoglutethimide in hyperfunction of the adrenal cortex (author's transl)].
    Marek J; Horký K; Gregorová I; Motlík K
    Sb Lek; 1974 Aug; 76(7):200-13. PubMed ID: 4603552
    [No Abstract]   [Full Text] [Related]  

  • 30. [Present knowledge on the treatment of Cushing's syndrome].
    Bricaire H; Albeaux-Fernet M; Lumbroso P; Netter A; Sebaoun J
    Presse Med (1893); 1969 Nov; 77(46):1665-8. PubMed ID: 5380390
    [No Abstract]   [Full Text] [Related]  

  • 31. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M; Luton JP; Mathieu de Fossey B; Bricaire H
    Presse Med (1893); 1968 May; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term effects of aminoglutethimide on steroid metabolism in congenital adrenal hyperplasia.
    Hamilton W
    Clin Chim Acta; 1976 Nov; 73(1):135-8. PubMed ID: 1000823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglutethimide in the treatment of Cushing's syndrome.
    Misbin RI; Canary J; Willard D
    J Clin Pharmacol; 1976; 16(11-12):645-51. PubMed ID: 993360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delay of hormonally induced diabetes by amino-glutethimide and metyrapone in partially pancreatectomized rats bearing transplantable pituitary tumors. Concomitant failure to prevent splanchnomegaly.
    Bates RW; Garrison MM
    Endocrinology; 1970 Jan; 86(1):107-19. PubMed ID: 4311190
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental congenital lipoid adrenal hyperplasia: prevention of anatomic defects produced by aminoglutethimide.
    Goldman AS
    Endocrinology; 1970 Nov; 87(5):889-93. PubMed ID: 5529931
    [No Abstract]   [Full Text] [Related]  

  • 36. [Surgical management of adrenal gland diseases].
    Cesnik H
    Zentralbl Chir; 1969 Dec; 94(49):1670-7. PubMed ID: 5382035
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of glycoactive hypercorticism].
    Jacobelli A; Agostino A; Altomonte G
    Clin Ter; 1984 Nov; 111(4):367-72. PubMed ID: 6098404
    [No Abstract]   [Full Text] [Related]  

  • 38. [O.p. DDD (lysodren) in treatment of adrenal cortex hyperfunction in childhood].
    Keller E; Willgerodt H; Teichmann B; Hoepffner W
    Kinderarztl Prax; 1981 Aug; 49(8):436-41. PubMed ID: 7289414
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cushing syndrome and adrenal hyperplasia].
    DE ANDRADE MA; VIANA T; FONSECA AS
    Med Cir Farm; 1956 May; (241):167-82. PubMed ID: 13347532
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of aminoglutethimide in the treatment of adrenal hyperfunction].
    Kasperlik-Załuska A; Migdalska B; Jeske W; Wiśniewska-Woźniak T
    Pol Arch Med Wewn; 1986 Dec; 76(5-6):249-57. PubMed ID: 3299304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.